Home/Filings/5/0001829126-25-000849
5//SEC Filing

Shelton Carolyn Hamby 5

Accession 0001829126-25-000849

CIK 0001527352other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 6:21 PM ET

Size

8.1 KB

Accession

0001829126-25-000849

Insider Transaction Report

Form 5
Period: 2024-12-31
Shelton Carolyn Hamby
Sr. VP - Quality, Regulatory
Transactions
  • Purchase

    Common stock

    2024-10-14$0.85/sh+24,000$20,40024,000 total
  • Award

    Stock Option (right to buy)

    2024-11-07+90,62090,620 total
    Exercise: $0.66Exp: 2029-09-25Common Stock (90,620 underlying)
Holdings
  • Common stock

    24,000
Footnotes (2)
  • [F1]Represents shares purchased after appointment as Senior Vice President, Quality, Regulatory and Clinical Affairs.
  • [F2]The reporting person was granted an option to purchase 90,620 shares of common stock. The option vests in three equal annual installments based on the satisfaction of certain performance criteria for each of the annual periods ending September 16, 2025, 2026 and 2027.

Issuer

Nexalin Technology, Inc.

CIK 0001527352

Entity typeother

Related Parties

1
  • filerCIK 0002053473

Filing Metadata

Form type
5
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 6:21 PM ET
Size
8.1 KB